Helene T. Cronje
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Robust human genetic evidence supporting causal effects of FGF21 on reducing alcohol consuming behaviours.
Journal: medRxiv : the preprint server for health sciences
Published: December 03, 2025
Opioid use disorder and dementia risk: evidence from observational and genetic analyses in diverse ancestry cohorts.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 23, 2025
Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study.
Journal: Circulation. Genomic and precision medicine
Published: March 07, 2025
Search for common genetic variants to allow reliable Mendelian randomization investigations into ketone metabolism.
Journal: European journal of epidemiology
Published: January 31, 2025
Associations of Genetically Predicted NPR3 and NPR2 Perturbation and Preeclampsia Risk: A Two-Sample Mendelian Randomization Analysis.
Journal: International journal of hypertension
Published: December 11, 2024
Human Genetic Evidence to Inform Clinical Development of IL-6 Signaling Inhibition for Abdominal Aortic Aneurysm.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: December 05, 2024
Common pitfalls in drug target Mendelian randomization and how to avoid them.
Journal: BMC medicine
Published: August 01, 2024
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition.
Journal: Journal of the American Heart Association
Published: June 14, 2024
Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: February 27, 2024
Last Updated: 09/26/2026